Literature DB >> 5926391

Ampicillin in the treatment of enterococcal endocarditis.

H N Beaty, M Turck, R G Petersdorf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5926391     DOI： 10.7326/0003-4819-65-4-701

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Which new penicillin?

Authors: 
Journal:  Calif Med       Date:  1968-10

Review 2.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

3.  Effect of pH and human serum on the susceptibility of group D streptococci (Enterococci) to ampicillin in vitro.

Authors:  D N Gilbert; N Eubanks
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

Review 4.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1967-03       Impact factor: 2.401

5.  Comparison of the action of ampicillin and benzylpenicillin on enterococci in vitro.

Authors:  M Sonne; E Jawetz
Journal:  Appl Microbiol       Date:  1968-04

Review 6.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

7.  Mode of action of lividomycin on protein synthesis in Escherichia coli.

Authors:  M Yamaguchi; J Eda; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

8.  Ampicillin therapy of experimental enterococcal endocarditis.

Authors:  R R Tight
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

9.  Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis.

Authors:  M L Fernández-Guerrero; C Barros; J L Rodriguez Tudela; R Fernández Roblas; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

10.  Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.

Authors:  W C Hellinger; M S Rouse; P M Rabadan; N K Henry; J M Steckelberg; W R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.